Drugs and Pharmaceuticals

The Texas Comptroller of Public Accounts Statewide Procurement Division is issuing an Invitation for Bids (IFB) No. 304T-26-269A1.1 for drugs and pharmaceuticals, with the Texas Department of Criminal Justice identified as a primary customer. The primary procurement focus is for multivitamins without iron, specifically 2,163 units referencing Natures Blend Multivitamin no Minerals or Natural Choice Multiple Vitamin Plus. The solicitation requires firm, all-inclusive, fixed pricing with potential escalation based on manufacturer price list changes, and vendors must factor in a 1.5% Texas SmartBuy administrative fee. Evaluation criteria will prioritize best value to the state, with price evaluation for line item 1 (multivitamins) based on lowest price per comparable unit. Key deliverable requirements include FDA compliance, specific manufacturing date standards, appropriate packaging, and UPC bar coding. The bid response is due on November 13, 2025, at 1:30 pm Central Time in Austin, TX, with electronic submission preferred via SPD.ebids@cpa.texas.gov.

The contract does not specify explicit set-aside designations or restrictions on respondent organizations, though the Execution of Response form indicates potential preferences for Texas-based businesses. Vendors must demonstrate compliance with various legal and operational requirements, including equal employment opportunity, antitrust laws, and ethical standards. The initial contract term will commence on the effective date of the Notice of Award and automatically expires on July 31, 2026, with four potential one-year renewal options extending through August 1, 2029. While specific award values are not explicitly stated, the procurement involves statewide delivery of pharmaceutical products. Respondents must provide comprehensive documentation, including an Execution of Response, Respondent Information, Insurance Statement of Intent, and a Mandatory Price Sheet. The contract includes provisions for legislative appropriations, potential state audits, and comprehensive terms governing intellectual property, confidentiality, and performance expectations.